A compound of formula
##STR1##
or a pharmaceutically acceptable salt thereof, wherein R is C(O)Ar1,
C(R4)(R5)Ar1 or Ar3; R3
represents a group XR10 or Ar2; X represents
a bond or a group NR11; and R10 represents C1-6
alkyl, C2-6 alkenyl or C2-6 alkynyl, each of which may be
optionally substituted by one or more substituents independently selected from
carboxyl, hydroxyl, C(O)R12, C3-6 cycloalkyl,
morpholinyl, NR13R14, SR15, OR16,
phenyl and halophenyl, or R10 represents a C3-6 cycloalkylcarbonyl,
C(O)CH2CN, halophenylcarbonyl or trifluoromethylcarbonyl group.
The compounds or compositions thereof are useful in the treatment or prophylaxis
of autoimmune, inflammatory, proliferative and hyperproliferative diseases.